NINJ2 and glioma: In established and primary human glioma cells, Ninj2 silencing (by targeted shRNAs) or knockout (by CRISPR/Cas9 method) potently inhibited cell survival, proliferation, migration and invasion, while inducing significant apoptosis activation.